The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia

  • Paulo C.J.L. Santos, Aline C. Morgan, Cinthia E. Jannes, José E. Krieger, Raul D. Santos, Alexandre C. Pereira
  • Pharmacogenetics and Genomics, November 2014, Wolters Kluwer Health
  • DOI: 10.1097/fpc.0000000000000089

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Jose Krieger